Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.22 USD
-0.02 (-1.61%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $1.28 +0.06 (4.92%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.19 | 0.00% |
Earnings Summary
For their last quarter, Aclaris Therapeutics (ACRS) reported earnings of -$0.24 per share, beating the Zacks Consensus Estimate of $-0.28 per share. This reflects a positive earnings surprise of 14.29%. Look out for ACRS's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 54.76%.
Earnings History
Price & Consensus
Zacks News for ACRS
SAGE Rides on Zurzuvae Sales, Pipeline Setbacks a Concern
ACRS: What are Zacks experts saying now?
Zacks Private Portfolio Services